Vecuronium
Description
Type: small molecule
Groups: approved
Indication: Vecuronium is a muscle relaxing agent and is used as an ajunct in general anesthesia.
Accession Number: DB01339 ( DB01339)
Description: Monoquaternary homolog of pancuronium. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other established neuromuscular blocking agents. [PubChem]
Structure:
Prescription Products:
Name | Dosage | Strength | Route | Marketing Start | Marketing End | Country |
Norcuron Inj 10mg/vial | powder for solution | 10 mg | intravenous | 31-12-1986 | 04-08-2009 | Canada |
Vecuronium Bromide for Injection | powder for solution | 10.00 mg | intravenous | 01-06-2000 | Canada | |
Vecuronium Bromide for Injection | powder for solution | 20.00 mg | intravenous | 28-01-2000 | Canada | |
Vecuronium Bromide for Injection | powder for solution | 10 mg | intravenous | 13-06-2000 | 15-02-2008 | Canada |
Generic Prescription Products:
Name | Dosage | Strength | Route | Marketing Start | Marketing End | Country |
Vecuronium | injection, powder, lyophilized, for solution | 10 mg/10mL | intravenous | 01-08-2011 | US | |
Vecuronium | injection, powder, lyophilized, for solution | 20 mg/20mL | intravenous | 01-08-2011 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 15-09-2010 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 11-05-2011 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 15-12-2014 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 11-05-2011 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 15-12-2014 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 21-07-2009 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 11-05-2011 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 11-05-2011 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 11-05-2011 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 21-10-1999 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 21-10-1999 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 11-05-2011 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 23-06-2015 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 01-08-2000 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 10 mg/10mL | intravenous | 25-08-1999 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 10 mg/10mL | intravenous | 14-11-2002 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 20 mg/20mL | intravenous | 14-11-2002 | US | |
Vecuronium Bromide for Injection | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 21-07-2009 | US | |
Vecuronium Bromide for Injection | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 21-07-2009 | US |
Over the Counter Products: Not Available
Prescription Products:
Name | Dosage | Strength | Route | Marketing Start | Marketing End | Country |
Norcuron Inj 10mg/vial | powder for solution | 10 mg | intravenous | 31-12-1986 | 04-08-2009 | Canada |
Vecuronium Bromide for Injection | powder for solution | 10.00 mg | intravenous | 01-06-2000 | Canada | |
Vecuronium Bromide for Injection | powder for solution | 20.00 mg | intravenous | 28-01-2000 | Canada | |
Vecuronium Bromide for Injection | powder for solution | 10 mg | intravenous | 13-06-2000 | 15-02-2008 | Canada |
Generic Prescription Products:
Name | Dosage | Strength | Route | Marketing Start | Marketing End | Country |
Vecuronium | injection, powder, lyophilized, for solution | 10 mg/10mL | intravenous | 01-08-2011 | US | |
Vecuronium | injection, powder, lyophilized, for solution | 20 mg/20mL | intravenous | 01-08-2011 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 15-09-2010 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 11-05-2011 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 15-12-2014 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 11-05-2011 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 15-12-2014 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 21-07-2009 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 11-05-2011 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 11-05-2011 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 11-05-2011 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 21-10-1999 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 21-10-1999 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 11-05-2011 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 23-06-2015 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 01-08-2000 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 10 mg/10mL | intravenous | 25-08-1999 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 10 mg/10mL | intravenous | 14-11-2002 | US | |
Vecuronium Bromide | injection, powder, lyophilized, for solution | 20 mg/20mL | intravenous | 14-11-2002 | US | |
Vecuronium Bromide for Injection | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 21-07-2009 | US | |
Vecuronium Bromide for Injection | injection, powder, lyophilized, for solution | 1 mg/mL | intravenous | 21-07-2009 | US |
International Brands
- No Brands
Brand Names
- No Brands
Brand Mixtures
Brand Name | Ingredients |
---|---|
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium | Vecuronium |
Vecuronium | Vecuronium |
Vecuronium Bromide for Injection | Vecuronium |
Vecuronium Bromide for Injection | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide for Injection | Vecuronium |
Vecuronium Bromide for Injection | Vecuronium |
Vecuronium Bromide for Injection | Vecuronium |
Norcuron Inj 10mg/vial | Vecuronium |
Brand Name | Ingredients |
---|---|
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium | Vecuronium |
Vecuronium | Vecuronium |
Vecuronium Bromide for Injection | Vecuronium |
Vecuronium Bromide for Injection | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide | Vecuronium |
Vecuronium Bromide for Injection | Vecuronium |
Vecuronium Bromide for Injection | Vecuronium |
Vecuronium Bromide for Injection | Vecuronium |
Norcuron Inj 10mg/vial | Vecuronium |
Categories
- No Category
Pharmacology
Pharmacodynamics: Not Available
Mechanism of action: Vecuronium is a bisquaternary nitrogen compound that acts by competitively binding to nicotinic cholinergic receptors. The binding of vecuronium decreases the opportunity for acetylcholine to bind to the nicotinic receptor at the postjunctional membrane of the myoneural junction. As a result, depolarization is prevented, calcium ions are not released and muscle contraction does not occur.
Absorption: Not Available
Volume of distribution: Not Available
Protein binding: Not Available
Metabolism: Not Available
Route of elimination: Fecal (40-75%) and renal (30% as unchanged drug and metabolites)
Half life: 51–80 minutes
Clearance: Not Available
Toxicity: Not Available
Affected organisms
- Not Available
SNP Mediated Adverse Drug Reactions
- Not Available
Pharmacoeconomics
- Not Available
Packagers:
- APP Pharmaceuticals
- Baxter International Inc.
- Bedford Labs
- Ben Venue Laboratories Inc.
- Cardinal Health
- Hospira Inc.
- Organon Pharmaceuticals
- Pharmedium
- Schein Pharmaceutical Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Watson Pharmaceuticals
- Zhejiang Xianju Pharmaceutical Co. Ltd.
Dosage forms
Form | Route | Strength |
---|---|---|
Injection, powder, lyophilized, for solution | intravenous | 1 mg/mL |
Injection, powder, lyophilized, for solution | intravenous | 10 mg/10mL |
Injection, powder, lyophilized, for solution | intravenous | 20 mg/20mL |
Powder for solution | intravenous | 10 mg |
Powder for solution | intravenous | 10.00 mg |
Powder for solution | intravenous | 20.00 mg |
Form | Route | Strength |
---|---|---|
Injection, powder, lyophilized, for solution | intravenous | 1 mg/mL |
Injection, powder, lyophilized, for solution | intravenous | 10 mg/10mL |
Injection, powder, lyophilized, for solution | intravenous | 20 mg/20mL |
Powder for solution | intravenous | 10 mg |
Powder for solution | intravenous | 10.00 mg |
Powder for solution | intravenous | 20.00 mg |
Prices
Unit description | Cost | Unit |
---|---|---|
Vecuronium 10 mg/10 ml syringe | $2.36 | ml |
Vecuronium 10 mg vial | $3.64 | vial |
Vecuronium 20 mg vial | $5.05 | vial |
Unit description | Cost | Unit |
---|---|---|
Vecuronium 10 mg/10 ml syringe | $2.36 | ml |
Vecuronium 10 mg vial | $3.64 | vial |
Vecuronium 20 mg vial | $5.05 | vial |
Patents
Country | Patent Number | Approved | Expires (estimated) |
---|
Interactions
Drug | Interaction |
---|---|
Amikacin | Amikacin may increase the activities of Vecuronium. |
Amlodipine | Amlodipine may increase the neuromuscular blocking activities of Vecuronium. |
Amrinone | Amrinone may increase the neuromuscular blocking activities of Vecuronium. |
Arbekacin | Arbekacin may increase the activities of Vecuronium. |
Bepridil | Bepridil may increase the neuromuscular blocking activities of Vecuronium. |
Botulinum Toxin Type A | Botulinum Toxin Type A may increase the neuromuscular blocking activities of Vecuronium. |
Botulinum Toxin Type B | Vecuronium may increase the neuromuscular blocking activities of Botulinum Toxin Type B. |
Capreomycin | Capreomycin may increase the neuromuscular blocking activities of Vecuronium. |
Carbamazepine | The serum concentration of Vecuronium can be decreased when it is combined with Carbamazepine. |
Clindamycin | Clindamycin may increase the neuromuscular blocking activities of Vecuronium. |
Colistimethate | Colistimethate may increase the neuromuscular blocking activities of Vecuronium. |
Cyclosporine | Cyclosporine may increase the neuromuscular blocking activities of Vecuronium. |
Dantrolene | Dantrolene may increase the neuromuscular blocking activities of Vecuronium. |
Digoxin | Vecuronium may increase the arrhythmogenic activities of Digoxin. |
Felodipine | Felodipine may increase the neuromuscular blocking activities of Vecuronium. |
Fludrocortisone | Vecuronium may increase the adverse neuromuscular activities of Fludrocortisone. |
Flunarizine | Flunarizine may increase the neuromuscular blocking activities of Vecuronium. |
Framycetin | Framycetin may increase the activities of Vecuronium. |
Gabapentin | Gabapentin may increase the neuromuscular blocking activities of Vecuronium. |
Gentamicin | Gentamicin may increase the activities of Vecuronium. |
Isoflurane | Isoflurane may increase the neuromuscular blocking activities of Vecuronium. |
Isradipine | Isradipine may increase the neuromuscular blocking activities of Vecuronium. |
Kanamycin | Kanamycin may increase the activities of Vecuronium. |
Ketorolac | The risk or severity of adverse effects can be increased when Ketorolac is combined with Vecuronium. |
Lamotrigine | Lamotrigine may increase the neuromuscular blocking activities of Vecuronium. |
Lercanidipine | Lercanidipine may increase the neuromuscular blocking activities of Vecuronium. |
Lincomycin | Lincomycin may increase the neuromuscular blocking activities of Vecuronium. |
Lithium | Lithium may increase the neuromuscular blocking activities of Vecuronium. |
Magnesium Sulfate | Magnesium Sulfate may increase the neuromuscular blocking activities of Vecuronium. |
Minocycline | Minocycline may increase the neuromuscular blocking activities of Vecuronium. |
Neomycin | Neomycin may increase the activities of Vecuronium. |
Netilmicin | Netilmicin may increase the activities of Vecuronium. |
Nicardipine | Nicardipine may increase the neuromuscular blocking activities of Vecuronium. |
Nimodipine | Nimodipine may increase the neuromuscular blocking activities of Vecuronium. |
Nisoldipine | Nisoldipine may increase the neuromuscular blocking activities of Vecuronium. |
Nitrendipine | Nitrendipine may increase the neuromuscular blocking activities of Vecuronium. |
Oxytetracycline | Oxytetracycline may increase the neuromuscular blocking activities of Vecuronium. |
Perhexiline | Perhexiline may increase the neuromuscular blocking activities of Vecuronium. |
Phenytoin | Phenytoin may decrease the neuromuscular blocking activities of Vecuronium. |
Piperacillin | Piperacillin may increase the neuromuscular blocking activities of Vecuronium. |
Polymyxin B Sulfate | Polymyxin B Sulfate may increase the neuromuscular blocking activities of Vecuronium. |
Prenylamine | Prenylamine may increase the neuromuscular blocking activities of Vecuronium. |
Procainamide | Procainamide may increase the neuromuscular blocking activities of Vecuronium. |
Quinidine | Quinidine may increase the neuromuscular blocking activities of Vecuronium. |
Quinine | Quinine may increase the neuromuscular blocking activities of Vecuronium. |
Ribostamycin | Ribostamycin may increase the activities of Vecuronium. |
Risedronate | Risedronate may increase the neuromuscular blocking activities of Vecuronium. |
Spectinomycin | Spectinomycin may increase the activities of Vecuronium. |
Spironolactone | Spironolactone may increase the neuromuscular blocking activities of Vecuronium. |
Streptomycin | Streptomycin may increase the activities of Vecuronium. |
Tacrine | Tacrine may decrease the neuromuscular blocking activities of Vecuronium. |
Tobramycin | Tobramycin may increase the activities of Vecuronium. |
Torasemide | Torasemide may decrease the neuromuscular blocking activities of Vecuronium. |
Vancomycin | Vancomycin may increase the neuromuscular blocking activities of Vecuronium. |
Verapamil | Verapamil may increase the neuromuscular blocking activities of Vecuronium. |
Drug | Interaction |
---|---|
Amikacin | Amikacin may increase the activities of Vecuronium. |
Amlodipine | Amlodipine may increase the neuromuscular blocking activities of Vecuronium. |
Amrinone | Amrinone may increase the neuromuscular blocking activities of Vecuronium. |
Arbekacin | Arbekacin may increase the activities of Vecuronium. |
Bepridil | Bepridil may increase the neuromuscular blocking activities of Vecuronium. |
Botulinum Toxin Type A | Botulinum Toxin Type A may increase the neuromuscular blocking activities of Vecuronium. |
Botulinum Toxin Type B | Vecuronium may increase the neuromuscular blocking activities of Botulinum Toxin Type B. |
Capreomycin | Capreomycin may increase the neuromuscular blocking activities of Vecuronium. |
Carbamazepine | The serum concentration of Vecuronium can be decreased when it is combined with Carbamazepine. |
Clindamycin | Clindamycin may increase the neuromuscular blocking activities of Vecuronium. |
Colistimethate | Colistimethate may increase the neuromuscular blocking activities of Vecuronium. |
Cyclosporine | Cyclosporine may increase the neuromuscular blocking activities of Vecuronium. |
Dantrolene | Dantrolene may increase the neuromuscular blocking activities of Vecuronium. |
Digoxin | Vecuronium may increase the arrhythmogenic activities of Digoxin. |
Felodipine | Felodipine may increase the neuromuscular blocking activities of Vecuronium. |
Fludrocortisone | Vecuronium may increase the adverse neuromuscular activities of Fludrocortisone. |
Flunarizine | Flunarizine may increase the neuromuscular blocking activities of Vecuronium. |
Framycetin | Framycetin may increase the activities of Vecuronium. |
Gabapentin | Gabapentin may increase the neuromuscular blocking activities of Vecuronium. |
Gentamicin | Gentamicin may increase the activities of Vecuronium. |
Isoflurane | Isoflurane may increase the neuromuscular blocking activities of Vecuronium. |
Isradipine | Isradipine may increase the neuromuscular blocking activities of Vecuronium. |
Kanamycin | Kanamycin may increase the activities of Vecuronium. |
Ketorolac | The risk or severity of adverse effects can be increased when Ketorolac is combined with Vecuronium. |
Lamotrigine | Lamotrigine may increase the neuromuscular blocking activities of Vecuronium. |
Lercanidipine | Lercanidipine may increase the neuromuscular blocking activities of Vecuronium. |
Lincomycin | Lincomycin may increase the neuromuscular blocking activities of Vecuronium. |
Lithium | Lithium may increase the neuromuscular blocking activities of Vecuronium. |
Magnesium Sulfate | Magnesium Sulfate may increase the neuromuscular blocking activities of Vecuronium. |
Minocycline | Minocycline may increase the neuromuscular blocking activities of Vecuronium. |
Neomycin | Neomycin may increase the activities of Vecuronium. |
Netilmicin | Netilmicin may increase the activities of Vecuronium. |
Nicardipine | Nicardipine may increase the neuromuscular blocking activities of Vecuronium. |
Nimodipine | Nimodipine may increase the neuromuscular blocking activities of Vecuronium. |
Nisoldipine | Nisoldipine may increase the neuromuscular blocking activities of Vecuronium. |
Nitrendipine | Nitrendipine may increase the neuromuscular blocking activities of Vecuronium. |
Oxytetracycline | Oxytetracycline may increase the neuromuscular blocking activities of Vecuronium. |
Perhexiline | Perhexiline may increase the neuromuscular blocking activities of Vecuronium. |
Phenytoin | Phenytoin may decrease the neuromuscular blocking activities of Vecuronium. |
Piperacillin | Piperacillin may increase the neuromuscular blocking activities of Vecuronium. |
Polymyxin B Sulfate | Polymyxin B Sulfate may increase the neuromuscular blocking activities of Vecuronium. |
Prenylamine | Prenylamine may increase the neuromuscular blocking activities of Vecuronium. |
Procainamide | Procainamide may increase the neuromuscular blocking activities of Vecuronium. |
Quinidine | Quinidine may increase the neuromuscular blocking activities of Vecuronium. |
Quinine | Quinine may increase the neuromuscular blocking activities of Vecuronium. |
Ribostamycin | Ribostamycin may increase the activities of Vecuronium. |
Risedronate | Risedronate may increase the neuromuscular blocking activities of Vecuronium. |
Spectinomycin | Spectinomycin may increase the activities of Vecuronium. |
Spironolactone | Spironolactone may increase the neuromuscular blocking activities of Vecuronium. |
Streptomycin | Streptomycin may increase the activities of Vecuronium. |
Tacrine | Tacrine may decrease the neuromuscular blocking activities of Vecuronium. |
Tobramycin | Tobramycin may increase the activities of Vecuronium. |
Torasemide | Torasemide may decrease the neuromuscular blocking activities of Vecuronium. |
Vancomycin | Vancomycin may increase the neuromuscular blocking activities of Vecuronium. |
Verapamil | Verapamil may increase the neuromuscular blocking activities of Vecuronium. |
Food Interactions:
- Not Available
Taxonomy
Super Class: Not Available
Class: Not Available
Sub Class: Not Available
Direct Parent: Not Available
Alternative Parents:
- Acetate salts
- Androstane steroids
- Azacyclic compounds
- Carbonyl compounds
- Carboxylic acid esters
- Cyclohexylamines
- Hydrocarbon derivatives
- Organic cations
- Piperidines
- Quaternary ammonium salts
- Trialkylamines
substituent:
- Acetate salt
- Aliphatic heteropolycyclic compound
- Amine
- Androstane-skeleton
- Azacycle
- Carbonyl group
- Carboxylic acid derivative
- Carboxylic acid ester
- Cyclohexylamine
- Hydrocarbon derivative
- Organic cation
- Organoheterocyclic compound
- Organonitrogen compound
- Organooxygen compound
- Piperidine
- Quaternary ammonium salt
- Steroid ester
- Tertiary aliphatic amine
- Tertiary amine
References
General Reference: Not Available
External Links:
Resource | Link |
---|---|
Drugs.com | http://www.drugs.com/cdi/vecuronium.html |
Resource | Link |
---|---|
Drugs.com | http://www.drugs.com/cdi/vecuronium.html |
ATC Codes:
- Array
AHFS Codes:
- 12:20.00
MSDS: Download